Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
VEGF signaling pathway | R-HSA-194138 | map04370 | betulin | 72326 | drug-path |
Asthma | R-HSA-444620 | map05310 | betulin | 72326 | drug-path |
GnRH signaling pathway | R-HSA-168638 | map04912 | betulin | 72326 | drug-path |
Allograft rejection | R-HSA-9679028 | map05330 | betulin | 72326 | drug-path |
Type I diabetes mellitus | R-HSA-5683209 | map04940 | betulin | 72326 | drug-path |
T cell receptor signaling pathway | R-HSA-983705 | map04660 | pronetalol | 10767 | drug-path |
Axon guidance | R-HSA-422475 | map04360 | pronetalol | 10767 | drug-path |
Graft-versus-host disease | R-HSA-1643685 | map05332 | pronetalol | 10767 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | pronetalol | 10767 | drug-path |
Autoimmune thyroid disease | R-HSA-1643685 | map05320 | pronetalol | 10767 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | pronetalol | 10767 | drug-path |
Ribosome | R-HSA-5368277 | map03010 | pronetalol | 10767 | drug-path |
Calcium signaling pathway | R-HSA-381753 | map04020 | pronetalol | 10767 | drug-path |
Allograft rejection | R-HSA-9679028 | map05330 | pronetalol | 10767 | drug-path |
Type I diabetes mellitus | R-HSA-5683209 | map04940 | pronetalol | 10767 | drug-path |
Graft-versus-host disease | R-HSA-1643685 | map05332 | sulfachlorpyridazine | 6634 | drug-path |
Hematopoietic cell lineage | R-HSA-173752 | map04640 | sulfachlorpyridazine | 6634 | drug-path |
Autoimmune thyroid disease | R-HSA-1643685 | map05320 | sulfachlorpyridazine | 6634 | drug-path |
Wnt signaling pathway | R-HSA-195721 | map04310 | sulfachlorpyridazine | 6634 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | sulfachlorpyridazine | 6634 | drug-path |